Status:
COMPLETED
Efficacy and Safety of Duloxetine
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Urinary Stress Incontinence
Eligibility:
FEMALE
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to monitor the long term safety and efficacy of duloxetine in the treatment of severe pure genuine stress incontinence.
Eligibility Criteria
Inclusion
- Female out patients.
- Have a diagnosis of pure genuine stress incontinence on urodynamic study performed within 6 months prior to study entry.
Exclusion
- Use of monoamine oxidase inhibitors within 14 days prior to study entry or at any time during the study.
- Suffer from severe constipation.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00190619
Start Date
May 1 2001
End Date
May 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST) or speak with your personal physician.
London, United Kingdom